The FDA’s SSRI Warning: "We’re from the Government, and We’re Here to Help"?
The FDA’s black-box warning about juvenile suicidality and SSRIs might have had unintended consequences: Prescription rates and depression diagnoses, including in adults, have decreased significantly.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)